NEW YORK (GenomeWeb News) – Australian biomarker-based diagnostic firm Healthlinx today announced a distribution deal to begin offering its OvPlex test in India in the third quarter.

The deal between Healthlinx and distribution partners Inex Innovations Exchange and Metropolis Healthcare will make OvPlex, an ovarian cancer diagnostic test, available initially in Mumbai beginning Aug. 1, with expansion into other major Indian cities in the months to follow.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.